These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

101 related items for PubMed ID: 5162181

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The effects of D1 and D2 dopamine receptor agonist and antagonist on parkinsonism in chronic MPTP-treated monkeys.
    Nomoto M, Fukuda T.
    Adv Neurol; 1993; 60():119-22. PubMed ID: 8093574
    [No Abstract] [Full Text] [Related]

  • 4. [Therapy and problems of parkinsonism].
    Albert E.
    Nervenarzt; 1971 May; 42(5):225-41. PubMed ID: 4942900
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Anatomo-clinical aspects of Parkinson's disease and parkinsonian syndromes].
    Gainotti G.
    Riv Neurol; 1978 May; 48(2):143-92. PubMed ID: 351788
    [No Abstract] [Full Text] [Related]

  • 7. [Certain features of the clinical picture and pathomorphology of Parkinson disease of different etiology].
    Martynov IuS, Zenkevich GS, Tochilovskiĭ AS.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1980 May; 80(7):1033-9. PubMed ID: 7415721
    [Abstract] [Full Text] [Related]

  • 8. Parkinsonism--neuropathology.
    Lewis PD.
    Br Med J; 1971 Sep 18; 3(5776):690-2. PubMed ID: 4936440
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The diagnosis of Parkinsonism or Parkinson syndrome.
    McDowell FH.
    Contemp Neurol Ser; 1971 Sep 18; 8():163-74. PubMed ID: 5162179
    [No Abstract] [Full Text] [Related]

  • 13. Dopamine-acetylcholine-glutamate interactions in the striatum. A working hypothesis.
    Di Chiara G, Morelli M.
    Adv Neurol; 1993 Sep 18; 60():102-6. PubMed ID: 8093571
    [No Abstract] [Full Text] [Related]

  • 14. Cholinergic and dopaminergic mechanisms in Parkinson's disease after long-term L-DOPA administration.
    Clough CG, Bergmann KJ, Yahr MD.
    Adv Neurol; 1984 Sep 18; 40():131-40. PubMed ID: 6695589
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Distribution of Alzheimer's neurofibrillar changes (NFA) in postencephalitic parkinsonism].
    Ishii T.
    Shinkei Kenkyu No Shimpo; 1968 Dec 18; 12(4):909-19. PubMed ID: 5753788
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.